In summary, glycosylation of a short relevant Her2 peptide induced functional antibodies to the short peptide core region, which subsequently were able to bind to and inhibit Her2 mediated SKBR3 breast carcinoma cell proliferation. This evidence concerns the gene ERBB2 and breast carcinoma.